Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer

doi:10.3748/wjg.15.6061

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 48

This Article

(0)

(4148)

(12)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Brief Article

World J Gastroenterol. Dec 28, 2009; 15(48): 6061-6067
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6061

Full Size Figure Download Figure

Figure 3 Overall survival of 122 resected gastric cancer patients based on GNAS1 T393C genotype with dichotomization between C+ and C- genotypes, P = 0. 043.

Citation: Alakus H, Mönig SP, Warnecke-Eberz U, Alakus G, Winde G, Drebber U, Schmitz KJ, Schmid KW, Riemann K, Siffert W, Bollschweiler E, Hölscher AH, Metzger R. Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer. World J Gastroenterol 2009; 15(48): 6061-6067
URL: https://www.wjgnet.com/1007-9327/full/v15/i48/6061.htm
DOI: https://dx.doi.org/10.3748/wjg.15.6061

Alakus H, Mönig SP, Warnecke-Eberz U, Alakus G, Winde G, Drebber U, Schmitz KJ, Schmid KW, Riemann K, Siffert W, Bollschweiler E, Hölscher AH, Metzger R. Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer. World J Gastroenterol 2009; 15(48): 6061-6067 [PMID: 20027678 DOI: 10.3748/wjg.15.6061]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.